Parkinson's disease: prospects for improved drug therapy
- 1 May 1997
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 18 (5) , 156-163
- https://doi.org/10.1016/s0165-6147(97)01050-x
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Fetal nigral transplantation as a therapy for Parkinson's diseaseTrends in Neurosciences, 1996
- Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- CabergolineDrugs, 1995
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanismsAnnals of Neurology, 1994
- N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's diseaseMovement Disorders, 1994
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's diseaseMovement Disorders, 1994
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- ParkinsonismNeurology, 1967